NCT06060093

Brief Summary

This study specifically aims to elucidate the effects of IEK on sleep and recuperation in hypoxia, after training in normoxia. These conditions are in line with the widely applied live-high train-low strategy. Moreover, blood and tissue oxygenation status, as well as cerebral blood flow and cognitive function will be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 20, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 29, 2023

Completed
Last Updated

September 29, 2023

Status Verified

September 1, 2023

Enrollment Period

1 month

First QC Date

August 29, 2023

Last Update Submit

September 27, 2023

Conditions

Keywords

ExerciseKetonesLiving-high Training-low

Outcome Measures

Primary Outcomes (4)

  • Duration of different sleep stages

    Measured using polysomnography

    Throughout the entire duration of the night, up to 9 hours after individual bedtime

  • Exercise performance

    Measured as the average power output (W) during a 30 minutes time trial

    30 minutes on the second morning of the protocol

  • Change in nocturnal oxygen saturation

    Measured using pulse oximetry

    Throughout the entire duration of the night, up to 9 hours after individual bedtime

  • Absolute amount of nocturnal urinary catecholamine excretion

    Measured using ELISA of collected nocturnal urine

    Subjects empty bladder before sleep and urine will be collected throughout the entire duration of the night, up to 9 hours after individual bedtime and in the morning immediately after waking up

Study Arms (3)

Normoxia - placebo

PLACEBO COMPARATOR

Both training and sleep in normoxia, supplemented with placebo

Dietary Supplement: Placebo

Hypoxia - placebo

EXPERIMENTAL

Training in normoxia and sleep in hypoxia, supplemented with placebo

Dietary Supplement: Placebo

Hypoxia - ketones

EXPERIMENTAL

Training in normoxia and sleep in hypoxia, supplemented with ketones

Dietary Supplement: Ketone ester

Interventions

PlaceboDIETARY_SUPPLEMENT

Water, 5% collagen(w/w), octoacetate (1 mM)

Hypoxia - placeboNormoxia - placebo
Ketone esterDIETARY_SUPPLEMENT

A total of 75g ketone ester supplementation will be administered in 3 bouts of 25g in order to establish intermittent exogenous ketosis: twice immediately after training, and one 30 minutes before sleep. The ketone ester used is (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Hypoxia - ketones

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Written informed consent must be obtained prior to any experimental procedures
  • Males between 18 and 35 years old
  • Recreational or competitive cyclists performing regular cycling training sessions with an average training volume of more than 6 hours per week
  • Good health status confirmed by a medical screening
  • Body Mass Index (BMI) between 18 and 25
  • Normal sleep pattern as assessed by the Pittsburgh Sleep Quality Index
  • Moderate sleep chronotype (extreme morning and evening chronotypes will be excluded), assessed by the Horne and Östberg questionnaire

You may not qualify if:

  • Any kind of injury/pathology that is a contra-indication for hypoxic exposure and/or to perform high-intensity exercise, evaluated by a sport medical screening
  • Intake of any medication or nutritional supplement that is known to affect exercise, performance or sleep. Intake will be assessed during recruitment and the sport medical screening.
  • Intake of analgesics, anti-inflammatory agents, or supplementary anti-oxidants, from 2 weeks prior to the start of the study.
  • Recent residence or training under hypoxia; more than 7 days exposure to altitude \> 1500m during the last 3 months preceding the study.
  • Night-shifts or travel across time zones in the month preceding the study
  • Blood donation within 3 months prior to the start of the study
  • Smoking
  • More than 3 alcoholic beverages per day
  • Pre-existing, diagnosed psychiatric conditions or diagnosed anxiety
  • Excessive daytime sleepiness as assessed by the Epworth scale
  • Depression or anxiety as assessed by the Beck Depression Inventory and Beck Anxiety Inventory. Only a score in the range of 'normal ups and downs' (score 1-10) for depression or 'minimal anxiety' (score 0-7) for anxiety are tolerated.
  • History of addiction or excessive caffeine/alcohol consumption assessed by a questionnaire
  • Any other argument to believe that the subject is unlikely to successfully complete the full study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

Location

Related Publications (1)

  • Stalmans M, Tominec D, Robberechts R, Lauriks W, Ramaekers M, Debevec T, Poffe C. A Single Night in Hypoxia Either with or without Ketone Ester Ingestion Reduces Sleep Quality without Impacting Next-Day Exercise Performance. Med Sci Sports Exerc. 2025 Apr 1;57(4):807-819. doi: 10.1249/MSS.0000000000003604. Epub 2024 Nov 18.

MeSH Terms

Conditions

KetosisHypoxiaMotor Activity

Interventions

formic acid 4-(3-oxobutyl)phenyl ester

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Chiel Poffé, Dr.

    KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: 1 session with both training and sleep in normoxia, supplemented with placebo (NPL) 1 session with training in normoxia, sleep in hypoxia, supplemented with placebo (HPL) 1 session with training in normoxia, sleep in hypoxia, supplemented with ketones (HKE)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 29, 2023

First Posted

September 29, 2023

Study Start

February 20, 2023

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

September 29, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations